Notice of special general meeting
Filed with HKEX · Stock code 858 · · 4 pages · English
Summary by 6ix AI
Extrawell Pharmaceutical Holdings Limited has issued a notice for a special general meeting to be held in Hong Kong. The meeting will consider a special resolution regarding a proposed share consolidation and capital reduction. The resolution includes consolidating existing shares and adjusting the par value of shares accordingly. The notice outlines the procedures for appointing proxies and voting at the meeting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Extrawell Pharmaceutical Holdings Limited on 6ix
Earlier from Extrawell Pharmaceutical
- Form of proxy for special general meeting to be held on Monday, 30 November 2026 at 10: 00 a.m.
- Proposed share consolidation; proposed capital reduction; proposed share sub-division; proposed change in board lot size and notice of special general meeting
- Further delay in despatch of the circular and further extension of the long stop date in relation to the major transaction involving the proposed fourth amendments to the terms and Conditions of the bonds
- Placing of new shares under general mandate
- Grant of share options to directors and connected transaction at subsidiary level in relation to the grant of share options to the service Provider
Later from Extrawell Pharmaceutical
- NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - Notice of Publication of Circular containing Notice of Special General Meeting dated 6 November 2026 and Proxy Form
- Monthly return of equity issuer on movements in securities for the month ended 31 October 2026
- Placing of new shares under general mandate supplemental announcement
Follow Extrawell Pharmaceutical into a list and get an email when it puts out news.
Follow Extrawell Pharmaceutical